-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Aclaris Therapeutis (ACRS)
-
-
-
-
-
-
-
Jefferies on Aclaris Therapeutis (ACRS): 'We see this data building the foundation to support upward momentum'
-
-
-
-
-
-
-
Piper Sandler Assumes Aclaris Therapeutis (ACRS) at Overweight, PT $6
-
-
-
-
-
-
-
Aclaris Therapeutis (ACRS) PT Lowered to $16 at H.C. Wainwright
-
-
-
-
-
-
-
Aclaris Therapeutics (ACRS) Forms New Scientific Advisory Board
-
-
-
-
-
-
-
Jefferies Upgrades Aclaris Therapeutis (ACRS) to Buy
-
-
-
-
-
-
-
BTIG Reiterates Neutral Rating on Aclaris Therapeutis (ACRS)
-
413,572 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

